from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3816c/-

LFCtreatmentdescriptionclass of inhibitor

-1.233

Amikacinug/mL Amikacintranslation

-0.189

Cap5-10ug/mL Capreomycintranslation

-0.976

Rox10-50 ug/mL Roxithromycintranslation

0.500

SM2-5 ug/mL Streptomycintranslation

-0.813

Tet5-10 ug/mL Tetracyclinetranslation

-2.781

Rif0.2-5ug/mL Rifampicintranscription

-1.689

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.041

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.809

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.216

CPZ10-50 ug/mL Chlorpromazinerespiration

0.716

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.067

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.486

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.241

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.340

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.304

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.426

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.733

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.929

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.208

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.859

KCN5-20 ug/mL Potassium cyaniderespiration

1.139

NaN30.2-2 mM Sodium aziderespiration

1.427

Nigericin50 uM Nigericinrespiration

-0.289

TRC10-150 ug/mL Triclosanrespiration

0.452

TRZ10-25 ug/mL Thioridazinerespiration

-0.313

Valinomycin0.5-10 uM Valinomycinrespiration

0.487

ZnSO42 mM ZnSO4respiration

1.241

menadione6-10 ug/mL Menadionerespiration

0.069

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.428

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.251

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.193

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.414

NRP_1Non-replicating persistence stage 1dosRassociated

0.227

Amp0.2mg/mL AmpicillincellWall

-0.304

Cephalexin20-100 ug/mL CephalexincellWall

-0.079

Cerulenin0.32-5 ug/mL CerulenincellWall

0.134

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.460

EMB10-20 ug/mL EthambutolcellWall

0.115

Eta12-40 ug/mL EthionamidecellWall

-0.448

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.202

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.160

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.483

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.252

BZA0.12 mg/mL BenzamidearomaticAmides

0.159

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.457

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.708

H2O24 mM hydrogen peroxideDNAdamaging

1.084

Levo10 ug/mL LevofloxacinDNAdamaging

-0.145

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.594

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.742

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.356

UVUV-irradiationDNAdamaging

-0.943

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.628

Antimycin12.5-50 ug/mL Antimycin A?

0.320

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.028

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.381

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.653

PA8240.2-2 ug/mL PA-824?

0.798

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.363

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.599

Verapamil50 uM Verapamil?

-0.058

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.041

methoxatin10-20 ug/mL Methoxatin?